CBPO [China Biologic Products] 6-K: (Original Filing)

[FOR RELEASE November 1, 2017 China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 --3Q17 Total Sales Up 15.1% YoY and Non-GAAP Adjusted Net Income Up 14.8% YoY in RMB terms, or Total Sales Up 15.1% YoY to $99.6 Million and Net Income Up 11.2% YoY to $31.6 Million in USD t]

CBPO [China Biologic Products] 6-K: FOR RELEASE November 1, 2017 China Biologic Reports

[FOR RELEASE November 1, 2017 China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 --3Q17 Total Sales Up 15.1% YoY and Non-GAAP Adjusted Net Income Up 14.8% YoY in RMB terms, or Total Sales Up 15.1% YoY to $99.6 Million and Net Income Up 11.2% YoY to $31.6 Million in USD t]

CBPO [China Biologic Products] 6-K: (Original Filing)

[FOR RELEASE October 12, 2017 China Biologic Agrees to Acquire TianXinFu from PWM Beijing, China—October 12, 2017— TianXinFu, a medical device company primarily engaging in the manufacturing and sale of regenerative medical biomaterial products, is currently owned as to 80% by PWM and 20% by a third ]

CBPO [China Biologic Products] 6-K: FOR RELEASE October 12, 2017 China Biologic Agrees

[FOR RELEASE October 12, 2017 China Biologic Agrees to Acquire TianXinFu from PWM Beijing, China—October 12, 2017— TianXinFu, a medical device company primarily engaging in the manufacturing and sale of regenerative medical biomaterial products, is currently owned as to 80% by PWM and 20% by a third ]

CBPO [China Biologic Products] SC 13G/A: (Original Filing)

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)..................]

CBPO [China Biologic Products] SC 13G/A: 1. Names of Reporting Persons. I.R.S. Identification Nos.

[1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). Baillie Gifford & Co (Scottish partnership) _______________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a)..................]

CBPO [China Biologic Products] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make ]

CBPO [China Biologic Products] 10-Q:

[] [CERTIFICATIONS I, David (Xiaoying) Gao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Biologic Products Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make ]

CBPO [China Biologic Products] S-8 POS:

[] [CHINA BIOLOGIC PRODUCTS HOLDINGS, INC. 2008 EQUITY INCENTIVE PLAN Purposes 1. Shares Subject to the Plan 2. If an Award granted under the Plan lapses, is forfeited, terminated or canceled, or expires without being exercised or without the issuance of Shares, the unissued and unpurchased Shares su]

Skip to toolbar